Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Investment Income (2022 - 2025)

Biofrontera (BFRI) has 3 years of Non Operating Investment Income data on record, last reported at $2000.0 in Q2 2025.

  • For Q2 2025, Non Operating Investment Income rose 114.29% year-over-year to $2000.0; the TTM value through Jun 2025 reached -$16000.0, up 99.47%, while the annual FY2024 figure was -$14000.0, 99.81% up from the prior year.
  • Non Operating Investment Income reached $2000.0 in Q2 2025 per BFRI's latest filing, up from -$2000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $3000.0 in Q1 2024 and bottomed at -$2.9 million in Q1 2023.
  • Average Non Operating Investment Income over 3 years is -$826000.0, with a median of -$14000.0 recorded in 2024.
  • Peak YoY movement for Non Operating Investment Income: surged 99.06% in 2024, then surged 114.29% in 2025.
  • A 3-year view of Non Operating Investment Income shows it stood at -$786000.0 in 2023, then soared by 99.75% to -$2000.0 in 2024, then soared by 200.0% to $2000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Investment Income were $2000.0 in Q2 2025, -$2000.0 in Q4 2024, and -$2000.0 in Q3 2024.